미국의 압박 요법 시장 : 규모, 점유율 및 동향 분석(기술별, 최종 용도별, 유통 채널별), 부문별 예측(2025-2030년)

U.S. Compression Therapy Market Growth & Trends:

The U.S. compression therapy market size is anticipated to reach USD 1.87 billion by 2030, exhibiting a CAGR of 2.82% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising rates of chronic venous disorders, such as chronic venous insufficiency (CVI) and deep vein thrombosis (DVT), drive demand for compression therapy. Compression therapy helps manage these conditions by improving blood circulation and reducing swelling.

According to the National Center for Biotechnology Information 2022, DVT affects more than 200,000 people in the U.S. Increased awareness about the benefits of compression therapy through educational campaigns and health promotion initiatives drives consumer demand. Understanding how compression therapy can alleviate symptoms and improve quality of life encourages adoption. The growing emphasis on preventive health and self-care encourages the use of compression therapy as a proactive measure to prevent or manage chronic conditions.

The shift towards home healthcare and outpatient care increases the demand for compression therapy products that can be used outside of clinical settings. This trend includes the use of compression garments and devices at home for ongoing condition management. Home healthcare services and online purchasing options make compression therapy products more accessible to patients. Improved reimbursement policies and insurance coverage for compression therapy products help reduce financial barriers for patients and healthcare providers, which facilitates the adoption of these products.

The pandemic led to increased awareness of the importance of medical supplies, including compression therapy products. Patients recovering from severe cases of COVID-19, especially those with extended hospital stays or who experienced complications such as deep vein thrombosis (DVT), have heightened demand for compression therapy. The pandemic caused significant disruptions in global supply chains, affecting the production and distribution of compression therapy products. Lockdowns, factory closures, and shipping delays impacted the availability of raw materials and finished goods. The pandemic accelerated research and development efforts in the healthcare sector, including the development of new compression therapy solutions that address both COVID-19-related complications and other health conditions.

The compression therapy market is subject to stringent regulatory requirements set by organizations such as the Food and Drug Administration. Ensuring compliance with these regulations can be challenging and costly for manufacturers. Advanced compression therapy products, such as those with smart technology or custom fittings, can be expensive. High costs may limit accessibility for some patients and healthcare facilities. Insurance coverage and reimbursement policies for compression therapy products can be inconsistent and vary widely among insurers. This variability can create financial burdens for patients and affect market growth. The quality and effectiveness of compression therapy products available in the market vary. Manufacturers face a challenge in ensuring that all products meet high standards for performance and safety.

U.S. Compression Therapy Market Report Highlights:

• Static compression therapy dominated the technology segment in 2024 due to the broad range of products, such as compression stockings, sleeves, and bandages.
• This variety caters to different patient needs and conditions, contributing to its market dominance.
• On the other hand, the dynamic compression therapy segment is expected to grow at the fastest CAGR.
• Based on end-use, hospitals segment dominated the market with a share of 31.14% in 2024.
• In 2024, the institutional sales segment dominated the market in 2024. Due to their high patient volume, institutions such as hospitals and large clinics procure compression therapy products in bulk, which drives significant sales through institutional channels.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Distribution channel outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Compression Therapy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic vein disorders
    • 3.2.1.2. Growing number of orthopedic procedures
    • 3.2.1.3. Growing incidence of obesity
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Alternative Treatment Method
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing number of clinical trials
    • 3.2.3.2. Technology Integration
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. High Costs
• 3.3. U.S. Compression Therapy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Compression Therapy Market: Technology Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Technology Market Share, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. U.S. Compression Therapy Market by Technology Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.6. Static Compression Therapy
  • 4.6.1. Static Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Compression Bandages
    • 4.6.2.1. Compression Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Compression Stockings
    • 4.6.3.1. Compression Stockings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. Compression Tape
    • 4.6.4.1. Compression Tape Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Others Compression Garments
    • 4.6.5.1. Others Compression Garments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Dynamic Compression Therapy
  • 4.7.1. Dynamic Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.2. Compression Pumps
    • 4.7.2.1. Compression Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.3. Compression Sleeves
    • 4.7.3.1. Compression Sleeves Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Compression Therapy Market: End Use Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. End Use Market Share, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. U.S. Compression Therapy Market by End Use Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Hospitals
    • 5.5.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Specialty Clinics
    • 5.5.2.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Home Healthcare
    • 5.5.3.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Physician's Office
    • 5.5.4.1. Physician's Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Nursing Homes
    • 5.5.5.1. Nursing Homes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Others
    • 5.5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Distribution Channel Market Share, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. U.S. Compression Therapy Market by Distribution Channel Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Institutional Sales
    • 6.5.1.1. Institutional Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Retail Sales
    • 6.5.2.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Cardinal Health
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Service Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. 3M
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Service Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. SIGVARIS GROUP
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Service Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Essity
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Service Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Julius Zorn, Inc.
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Service Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. HARTMANN USA, Inc
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Service Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. Bauerfeind USA Inc.
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Service Benchmarking
    • 7.3.10.4. Strategic Initiatives
  • 7.3.11. medi USA
    • 7.3.11.1. Company Overview
    • 7.3.11.2. Financial Performance
    • 7.3.11.3. Service Benchmarking
    • 7.3.11.4. Strategic Initiatives
  • 7.3.12. BIOCOMPRESSION SYSTEMS
    • 7.3.12.1. Company Overview
    • 7.3.12.2. Financial Performance
    • 7.3.12.3. Service Benchmarking
    • 7.3.12.4. Strategic Initiatives
  • 7.3.13. Gottfried Medical, Inc.
    • 7.3.13.1. Company Overview
    • 7.3.13.2. Financial Performance
    • 7.3.13.3. Service Benchmarking
    • 7.3.13.4. Strategic Initiatives